Validation of generic preference-based measures to assess quality of life in Parkinson’s disease

Takeaway

  • The study identified several missing disease-specific domains from the generic preference-based measures currently used to evaluate health-related quality of life (HRQL) in people with Parkinson’s disease (PD).

Why this matters

  • Validation of content in generic preference-based measures is crucial for accurate assessment of HRQL in people with PD, clinical trials and determination of cost-effectiveness of interventions.